Skip to content

All the news from Servier Group

Home > Suspension of the Marketing Authorisations and withdrawal of fenspiride based drugs (Pneumorel and Eurespal) from the market
Back to news

Suspension of the Marketing Authorisations and withdrawal of fenspiride based drugs (Pneumorel and Eurespal) from the market

For France for more information click here.

For other countries, please contact the local Servier subsidiary in your country.